Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jayant Agro-Organics Limited (JAYAGROGN.NS)
Mumbai, MA, IN
Jayant Agro-Organics Limited is a global entity specializing in the manufacturing and worldwide distribution of castor oil and its diverse derivatives. The company structures its operations across three primary segments: Castor Oil, Derivatives, and Power Generation. Its comprehensive product range encompasses various forms of castor oil, including blown, dehydrated, hydrogenated, and ethoxylated types, alongside specialty chemicals such as 12-hydroxy stearic acid, sebacic acid, 2-octanone, HIOL fatty acid, and ricinoleic acid. Supplementary offerings include castor meal, glycerine, jagrolube, and jagropol. These products are critically utilized in a broad spectrum of industries, including agriculture, cosmetics, electronics, lubricants, paints, perfumeries, pharmaceuticals, polymers, plastics, rubber, and textiles. Beyond its core chemical business, the company also participates in power generation. Founded in 1992 and based in Mumbai, India, Jayant Agro-Organics Limited functions as a subsidiary of Jayant Finvest Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.99% | -3.05% | +14.66% | +28.07% | +5.90% | +9.95% | -12.83% | +20.84% | +17.72% | +130.11% | +183,324.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-4.9% Q1'26: +2.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-8.2% Q1'26: +53.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.3% Q1'26: -9.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.4% Q1'26: +4.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+7.8% ★ Q1'26: +10.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%0.0% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.26× Q1'26: 0.98× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
16.43B
est: 17.51B (-6.2%)
|
24.88B
est: 25.43B (-2.2%)
|
24.25B
est: 24.13B (+0.5%)
|
24.72B
est: 27.01B (-8.5%)
|
16.16B
est: 29.71B (-45.6%)
|
25.30B
est: 17.51B (+44.5%)
|
25.43B
25.43B – 25.43B
+45.3% YoY
|
24.13B
24.13B – 24.13B
-5.1% YoY
|
27.01B
27.01B – 27.01B
+12.0% YoY
|
29.71B
29.71B – 29.71B
+10.0% YoY
|
| EBITDA |
1.29B
est: 865.16M (+48.5%)
|
1.51B
est: 1.26B (+20.0%)
|
1.46B
est: 1.19B (+22.9%)
|
-80.46M
est: 656.16M (-112.3%)
|
984.63M
est: 1.47B (-32.9%)
|
1.10B
est: 865.16M (+27.7%)
|
1.26B
1.26B – 1.26B
+45.3% YoY
|
1.19B
1.19B – 1.19B
-5.1% YoY
|
1.33B
1.33B – 1.33B
+12.0% YoY
|
1.47B
1.47B – 1.47B
+10.0% YoY
|
| EBIT |
1.17B
est: 744.35M (+56.5%)
|
1.38B
est: 1.08B (+27.3%)
|
1.34B
est: 1.03B (+31.0%)
|
-215.58M
est: 1.54B (-114.0%)
|
870.58M
est: 1.26B (-31.1%)
|
910.46M
est: 744.35M (+22.3%)
|
1.08B
1.08B – 1.08B
+45.3% YoY
|
1.03B
1.03B – 1.03B
-5.1% YoY
|
1.15B
1.15B – 1.15B
+12.0% YoY
|
1.26B
1.26B – 1.26B
+10.0% YoY
|
| Net Income |
535.71M
est: 530.09M (+1.1%)
|
534.66M
est: 579.75M (-7.8%)
|
558.04M
est: 578.85M (-3.6%)
|
-321.61M
est: 669.98M (-148.0%)
|
479.94M
est: 704.89M (-31.9%)
|
549.14M
est: 530.06M (+3.6%)
|
579.72M
579.72M – 579.72M
+9.4% YoY
|
578.82M
578.82M – 578.82M
-0.2% YoY
|
636.43M
636.43M – 636.43M
+10.0% YoY
|
704.84M
704.84M – 704.84M
+10.7% YoY
|
| SGA |
642.30M
est: 733.58M (-12.4%)
|
712.72M
est: 1.07B (-33.1%)
|
737.27M
est: 1.01B (-27.1%)
|
687.82M
est: 463.89M (+48.3%)
|
705.84M
est: 1.24B (-43.3%)
|
988.31M
est: 733.58M (+34.7%)
|
1.07B
1.07B – 1.07B
+45.3% YoY
|
1.01B
1.01B – 1.01B
-5.1% YoY
|
1.13B
1.13B – 1.13B
+12.0% YoY
|
1.24B
1.24B – 1.24B
+10.0% YoY
|
| EPS |
18.31
est: 17.67 (+3.7%)
|
17.82
est: 19.32 (-7.8%)
|
18.60
est: 19.29 (-3.6%)
|
-10.72
est: 21.21 (-150.5%)
|
16.00
est: 23.49 (-31.9%)
|
18.30
est: 17.67 (+3.6%)
|
19.32
19.32 – 19.32
+9.4% YoY
|
19.29
19.29 – 19.29
-0.2% YoY
|
21.21
21.21 – 21.21
+10.0% YoY
|
23.49
23.49 – 23.49
+10.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Abhay Vithaldas Udeshi | Chairman | 14M | male |
| Subhash Vithaldas Udeshi | Director of Technical & Joint MD | 12M | — |
| Hemant Vithaldas Udeshi | MD & Executive Director | 12M | male |
| Varun Abhay Udeshi | Whole-Time Director | 12M | male |
| Dinesh Mathuradas Kapadia | Company Secretary, Compliance Officer & Nodal Officer | — | male |
| Vikram V. Udeshi | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for JAYAGROGN.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
